{
    "Trade/Device Name(s)": [
        "Eon Cholesterol Reagent"
    ],
    "Submitter Information": "Vital Diagnostics Pty Ltd",
    "510(k) Number": "k120202",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "CHH"
    ],
    "Summary Letter Date": "June 13, 2012",
    "Summary Letter Received Date": "June 21, 2012",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21 CFR 862.1175"
    ],
    "Regulation Name(s)": [
        "Cholesterol (total) test system"
    ],
    "Analyte Class(es)": [
        "chemistry"
    ],
    "Analyte(s)": [
        "Cholesterol (total)"
    ],
    "Specimen Type(s)": [
        "Plasma",
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Eon 100 Clinical Chemistry Analyser"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent"
    ],
    "Document Summary": "FDA 510(k) summary for Eon Cholesterol Reagent for quantitative determination of total cholesterol in plasma and serum using Eon 100 Clinical Chemistry Analyser",
    "Indications for Use Summary": "Intended for quantitative determination of total cholesterol in human plasma and serum to aid diagnosis and treatment of disorders involving excess cholesterol and lipid metabolism using the Eon 100 Clinical Chemistry Analyser",
    "fda_folder": "Clinical Chemistry"
}